OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial

Clinical outcomes in immunotherapy can be substantially improved by using clinical diagnostic assays that can reliably match the right subject with the right drug. In doing so, it becomes necessary to choose an assay that can perform prospective profiling of a comprehensive range of immune gene expression markers. In this case study, we highlight how the OmniSeq INSIGHT assay was used to examine immune-related gene expression to stratify subjects into different arms of an ongoing, investigator-initiated clinical trial, thereby matching subjects with the most suitable treatment and trial arm.